A Semi-Annual Publication for the Ridgeview Institute Recovering Professionals Alumni Association
| Volume 1 Issue 1 | June 2, 2006

Inside This Issue

History of R2P2
2  Meet the Treatment Team
  Function of the Aftercare Program

  Rules Regarding Use of  Medication
  Nurse Advocacy
6  Participants’ Corner
  Upcoming Events
8  Subscribe
9  Address Change

The Ridgeview Recovering Professionals Aftercare Program serves as a monitoring and advocacy component to our treatment program.

Safe Drug Use for the Recovering Addict or Alcoholic

Click here

Rules Regarding Use of Medications

As mentioned previously, the aftercare program assesses relapse behavior in early stages and uses compliance in certain areas for its assessment.  One very significant factor for persons being monitored for addiction issues is adhering to Rules Regarding Use of Medications:

  • You must notify Administrative Assistant, Dru Barber, ext.3328, of all the medications you are currently taking - even over-the-counter medications.
  • All prescription medications require a doctor’s prescription and you must have a bonafide patient-doctor relationship with that physician. 
  • If a medication is prescribed, please call Dru Barber immediately.  Using  mood-altering medications on a non-emergency basis without prior notification to your addictionologist, nurse advocate, aftercare coordinator, may be considered to be relapsive.

What is NOT OK for Chemical Dependency Participants?

  • Use of another person’s medication
  • Use of prescription drugs without a valid, recent prescription
  • Mixing your medications with someone else’s
  • Foods containing poppy seeds
  • Medication containing ephedrine
  • Medication containing alcohol
  • Muscle relaxers (such as Soma or Flexeril) without program approval
  • Sleeping medications such as Ambien, Sonata or benzodiazepines
  • Prescription diet pills or over-the-counter diet pills
  • Tramadol (Ultram)
  • Medications with narcotics
  • Mouthwash with alcohol
  • Cough medicine (pills and syrups) with narcotics or dextromethorphan

Submit information, articles, ideas, and suggestions for this newsletter/resource page to Chad Husted, Director of Business Development at Ridgeview Institute – (770) 434-4568, ext 3011 or e-mail: tlopes@ridgeviewinstitute.com